Avidity Biosciences, Inc. (RNAM)

Avidity Biosciences Statistics

Total Valuation

RNAM has a market cap or net worth of $11.30 billion. The enterprise value is $9.65 billion.

Market Cap	11.30B
Enterprise Value	9.65B

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

RNAM has 155.15 million shares outstanding. The number of shares has increased by 23.42% in one year.

Current Share Class	155.15M
Shares Outstanding	155.15M
Shares Change (YoY)	+23.42%
Shares Change (QoQ)	+11.68%
Owned by Insiders (%)	5.92%
Owned by Institutions (%)	85.48%
Float	132.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	602.40
Forward PS	n/a
PB Ratio	6.52
P/TBV Ratio	6.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	514.55
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.20, with a Debt / Equity ratio of 0.03.

Current Ratio	9.20
Quick Ratio	8.75
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.98% and return on invested capital (ROIC) is -29.42%.

Return on Equity (ROE)	-43.98%
Return on Assets (ROA)	-26.47%
Return on Invested Capital (ROIC)	-29.42%
Return on Capital Employed (ROCE)	-42.32%
Weighted Average Cost of Capital (WACC)	9.33%
Revenue Per Employee	$36,703
Profits Per Employee	-$1.34M
Employee Count	511
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +149.73% in the last 52 weeks. The beta is 0.93, so RNAM's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+149.73%
50-Day Moving Average	72.52
200-Day Moving Average	52.68
Relative Strength Index (RSI)	58.43
Average Volume (20 Days)	4,167,552

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, RNAM had revenue of $18.76 million and -$684.63 million in losses. Loss per share was -$4.97.

Revenue	18.76M
Gross Profit	-540.40M
Operating Income	-745.94M
Pretax Income	-684.63M
Net Income	-684.63M
EBITDA	-741.79M
EBIT	-745.94M
Loss Per Share	-$4.97

Balance Sheet

The company has $1.70 billion in cash and $49.25 million in debt, with a net cash position of $1.65 billion or $10.62 per share.

Cash & Cash Equivalents	1.70B
Total Debt	49.25M
Net Cash	1.65B
Net Cash Per Share	$10.62
Equity (Book Value)	1.69B
Book Value Per Share	11.17
Working Capital	1.60B

Cash Flow

In the last 12 months, operating cash flow was -$650.44 million and capital expenditures -$13.32 million, giving a free cash flow of -$663.76 million.

Operating Cash Flow	-650.44M
Capital Expenditures	-13.32M
Free Cash Flow	-663.76M
FCF Per Share	-$4.28

Margins

Gross Margin	n/a
Operating Margin	-3,977.30%
Pretax Margin	-3,650.39%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RNAM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.42%
Shareholder Yield	-23.42%
Earnings Yield	-6.06%
FCF Yield	-5.88%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RNAM has an Altman Z-Score of 11.03 and a Piotroski F-Score of 2.

Altman Z-Score	11.03
Piotroski F-Score	2